loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Benidipine reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Benidipine

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,139Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Coniel

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2020 Revenue in Millions : 30

    2019 Revenue in Millions : 38

    Growth (%) : -20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2021 Revenue in Millions : 23

    2020 Revenue in Millions : 30

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 15

    2021 Revenue in Millions : 23

    Growth (%) : -34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 10

    2022 Revenue in Millions : 15

    Growth (%) : -25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2017 Revenue in Millions : 60

    2016 Revenue in Millions : 73

    Growth (%) : -17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2018 Revenue in Millions : 43

    2017 Revenue in Millions : 57

    Growth (%) : -24%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Coniel

    Benidipine

    arrow
    Boulder Peptide 2024
    Not Confirmed

    Brand Name : Coniel

    Japan
    arrow
    Boulder Peptide 2024
    Not Confirmed

    Kyowa Kirin

    Benidipine

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2019 Revenue in Millions : 37

    2018 Revenue in Millions : 45

    Growth (%) : -17

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF